Physician profile
John C Lipman
NPI 1124096219
$1,898.80
in general payments reported to CMS, 2019-2025
21 companies · $145 in 2025
The $145 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $480 · 2020: $158 · 2021: $54.44 · 2022: $220 · 2023: $421 · 2024: $421 · 2025: $145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $897 · Gift: $89.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $896.78 |
| Gift | $89.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiva Medical, INC. | $251.07 | 2019-2024 | Cardiva Vascade 5f Vcs, Cardiva Vascade 6/7f Vcs |
| Boston Scientific Corporation | $231.29 | 2021-2025 | Therasphere Y90 Glass Microspheres 10 Gbq, Renegade |
| Philips North America LLC | $184.64 | 2019 | |
| Vasorum USA INC. | $174.32 | 2023 | Celt Acd |
| Merit Medical Systems INC | $126.89 | 2020-2023 | Aspira, Safeguard Radial Compress Dev, Swiftninja Sterble Cor Micro |
| Medtronic Vascular, INC. | $123.73 | 2019 | |
| Cms Imaging, INC. | $122.90 | 2024-2025 | |
| Medtronic, INC. | $111.36 | 2022 | |
| Nevro Corp. | $110.00 | 2024 | Senza |
| Boehringer Ingelheim Pharmaceuticals, INC. | $108.85 | 2019 | |
| Varian Medical Systems, INC. | $69.05 | 2020 | |
| Angiodynamics, INC. | $58.58 | 2020-2022 | |
| Trisalus Life Sciences, INC. | $58.24 | 2024 | Trinav Infusion System |
| Bard Peripheral Vascular, INC. | $56.50 | 2020 | |
| Siemens Medical Solutions USA, INC. | $28.25 | 2023 | Embozene |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $21.40 | 2019 | |
| Guerbet LLC | $19.82 | 2021 | |
| Medline Industries LP | $15.29 | 2024 | |
| Asahi Intecc USA, INC. | $15.00 | 2025 | Asahi Interventional Radiology Wires |
| Meditrina | $11.62 | 2023 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$3.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Lipman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.